RET and neoplasm: According to recent reports, such mutation pattern may also distinguish certain tumor types from the other ones, which has been validated to be pathogenic in a specific oncogene named RET for thyroid carcinoma (Colombo-Benkmann et al., 2008), confirming our prediction.